Stericycle, Inc. (SRCL) Director Mark C. Miller Sells 19,753 Shares

Stericycle, Inc. (NASDAQ:SRCL) Director Mark C. Miller sold 19,753 shares of the company’s stock in a transaction dated Monday, October 30th. The stock was sold at an average price of $70.52, for a total transaction of $1,392,981.56. Following the completion of the transaction, the director now owns 205,576 shares in the company, valued at approximately $14,497,219.52. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Stericycle, Inc. (SRCL) opened at 70.85 on Wednesday. The firm’s 50-day moving average is $71.33 and its 200 day moving average is $76.59. The company’s market cap is $6.05 billion. Stericycle, Inc. has a 1-year low of $68.62 and a 1-year high of $88.00.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings results on Thursday, August 3rd. The business services provider reported $1.15 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.13 by $0.02. Stericycle had a positive return on equity of 14.35% and a negative net margin of 0.07%. The business had revenue of $917.70 million for the quarter, compared to analyst estimates of $902.81 million. During the same quarter in the previous year, the firm earned $1.18 earnings per share. The company’s revenue was up 2.9% on a year-over-year basis. Analysts predict that Stericycle, Inc. will post $4.59 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This news story was originally reported by Community Financial News and is owned by of Community Financial News. If you are viewing this news story on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The legal version of this news story can be viewed at https://www.com-unik.info/2017/11/01/stericycle-inc-srcl-director-mark-c-miller-sells-19753-shares.html.

Hedge funds have recently modified their holdings of the company. Pacer Advisors Inc. grew its stake in shares of Stericycle by 8.4% during the second quarter. Pacer Advisors Inc. now owns 1,880 shares of the business services provider’s stock worth $143,000 after acquiring an additional 145 shares during the last quarter. Smith Shellnut Wilson LLC ADV purchased a new stake in shares of Stericycle during the second quarter worth about $223,000. Benjamin F. Edwards & Company Inc. grew its stake in shares of Stericycle by 8.5% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 2,540 shares of the business services provider’s stock worth $194,000 after acquiring an additional 200 shares during the last quarter. Intact Investment Management Inc. purchased a new stake in shares of Stericycle during the second quarter worth about $237,000. Finally, Douglass Winthrop Advisors LLC grew its stake in shares of Stericycle by 6.5% during the second quarter. Douglass Winthrop Advisors LLC now owns 3,120 shares of the business services provider’s stock worth $238,000 after acquiring an additional 190 shares during the last quarter. Institutional investors and hedge funds own 93.92% of the company’s stock.

A number of brokerages recently issued reports on SRCL. Barclays PLC reiterated an “overweight” rating and issued a $100.00 price target on shares of Stericycle in a research note on Wednesday, August 9th. William Blair reiterated an “ourperform” rating on shares of Stericycle in a research note on Thursday, September 14th. BidaskClub upgraded shares of Stericycle from a “strong sell” rating to a “sell” rating in a research note on Monday, July 24th. Jefferies Group LLC set a $108.00 price target on shares of Stericycle and gave the stock a “buy” rating in a research note on Tuesday, October 17th. Finally, Zacks Investment Research cut shares of Stericycle from a “buy” rating to a “hold” rating in a research note on Monday, August 7th. Four equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the company’s stock. Stericycle has a consensus rating of “Hold” and a consensus target price of $81.25.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

What are top analysts saying about Stericycle Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Stericycle Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit